Metraipolis › archive › dc_f021e031980a

γ-Oryzanol-Loaded PLGA nanoparticles: enhanced drug delivery and therapeutic efficacy for breast cancer therapy — Europe PMC PMID:40969227

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40969227
DOI
10.3389/fbioe.2025.1675338
License (as archived)
solo-consultazione
Archived
2026-11-10T03:48:05.968Z
SHA-256 of the archived text
033c2d3a499906d4b33a98db1f4bb3c805016ce3a0c1634f7ccbbcd9d4ddadd0
Stable URL of this page
https://metraipolis.com/documento/dc_f021e031980a

How to cite

γ-Oryzanol-Loaded PLGA nanoparticles: enhanced drug delivery and therapeutic efficacy for breast cancer therapy — Europe PMC PMID:40969227 — Europe PMC (en), https://europepmc.org/article/MED/40969227 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f021e031980a (Metraipolis archive dc_f021e031980a, sha256 033c2d3a499906d4b33a98db1f4bb3c805016ce3a0c1634f7ccbbcd9d4ddadd0)
BibTeX
@misc{dcf021e031980a,
  title = {γ-Oryzanol-Loaded PLGA nanoparticles: enhanced drug delivery and therapeutic efficacy for breast cancer therapy — Europe PMC PMID:40969227},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40969227},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f021e031980a; sha256 033c2d3a499906d4b33a98db1f4bb3c805016ce3a0c1634f7ccbbcd9d4ddadd0},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40969227. Agents can read the archived copy with the MCP tool read_document.